IP Library Granted Patent US 8,088,365
Granted Patent B2
US 8,088,365 · App. 12/414,621 · Granted Jan 3, 2012

Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,365
App. No.
12/414,621
Granted
Jan 3, 2012
Kind
B2
Abstract

PEG and related polymer derivatives having weak, hydrolytically unstable linkages near the reactive end of the polymer are provided for conjugation to drugs, including proteins, enzymes, small molecules, and others. These derivatives provide a sufficient circulation period for a drug-PEG conjugate, followed by hydrolytic breakdown of the conjugate and release of the bound molecule. In some cases, drugs that demonstrate reduced activity when permanently coupled to PEG maintain a therapeutically suitable activity when coupled to a degradable PEG in accordance with the invention. The PEG derivatives of the invention can be used to impart improved water solubility, increased size, a slower rate of kidney clearance, and reduced immunogenicity to a conjugate formed by attachment thereto. Controlled hydrolytic release of the bound molecule into an aqueous environment can then enhance the drug's delivery profile by providing a delivery system which employs such polymers and utilizes the teachings provided herein.

Claims (20)

1. A polymer having the following structure:

POLY(-W-T) n

wherein:

POLY is a four-arm, branched PEG having a molecular weight from 300 to 100,000 daltons and having a pentaerythritol core;

W is a linkage comprising an ester;

T is a succinimidyl ester; and

n is four.

2. The polymer of claim 1 , wherein the linkage comprising an ester is —O—(CH 2 ) n′ —CO 2 —(CH 2 ) m —, wherein n′ is 1 to 5 and m is 2 to 5.

3. The polymer of claim 1 , wherein the succinimidyl ester is —CO 2 —succinimidyl.

4. A method of forming a coupled product, the method comprising reacting a polymer having the following structure: POLY(-W-T) n , with an amine-containing molecule under conditions effective to couple the polymer to the amine-containing molecule to thereby form the coupled product,

wherein:

POLY is a four-arm, branched PEG having a molecular weight from 300 to 100,000 daltons and having a pentaerythritol core;

W is a linkage comprising an ester;

T is a succinimidyl ester; and

n is four.

5. The method of claim 4 , wherein the linkage comprising an ester is —O—(CH 2 ) n′ —CO 2 —(CH 2 ) m —, wherein n′ is 1 to 5 and m is 2 to 5.

6. The method of claim 4 , wherein the succinimidyl ester is —CO 2 —succinimidyl.

7. The method of claim 4 , wherein the amine-containing molecule is a peptide.

8. The method of claim 4 , wherein: the succinimidyl ester is —CO 2 -succinimidyl; and the amine-containing molecule is a peptide.

9. A composition comprising the coupled product formed by the method of claim 4 .

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →